Understanding key terms
These terms may help you prepare for conversations with your care team about what’s next in your treatment journey. Click the words below to get definitions for frequently used phrases.
Treatment that uses chemicals to kill fast-growing cells in the body. This includes cancer cells.
When tumors disappear with treatment.
Treatment that interferes with the effects of testosterone.
Possible side effect of PLUVICTO, someone with low blood platelet count struggles to stop bleeding. This could mean you bruise easily or bleed more than usual from a small cut.
Possible side effect of PLUVICTO, a low red blood cell count affects your ability to fight infections. Symptoms may include tiredness, shortness of breath, and chest pain.
A type of advanced prostate cancer that has spread outside the prostate. It also no longer responds as well to certain hormone treatments.
The total percentage of patients whose cancer responds to treatment in a clinical trial. Their tumors disappear or shrink in size.
Measure of how long patients live after they are assigned treatment in a clinical trial.
When a treatment decreases a tumor’s size.
A substance made by the prostate that may be found in higher-than-normal levels in the blood of men who have prostate cancer. PSA levels are found through a blood test.
A biomarker commonly found on the outside of prostate cancer cells and some normal cells. A PSMA-PET scan can find PSMA+ cells in your body.
An imaging test that can help find PSMA+ cells, including prostate cancer cells, in your body.
In a clinical trial, how long patients live without their cancer getting worse after being assigned treatment. It is determined by imaging tests.